Logo image of CLA.PA

CLARANOVA SE (CLA.PA) Stock Fundamental Analysis

Europe - EPA:CLA - FR0013426004 - Common Stock

1.828 EUR
+0.08 (+4.46%)
Last: 10/24/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CLA. CLA was compared to 111 industry peers in the Software industry. While CLA is still in line with the averages on profitability rating, there are concerns on its financial health. CLA has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CLA had negative earnings in the past year.
CLA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CLA reported negative net income in multiple years.
CLA had a positive operating cash flow in each of the past 5 years.
CLA.PA Yearly Net Income VS EBIT VS OCF VS FCFCLA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

The Return On Assets of CLA (-1.14%) is comparable to the rest of the industry.
CLA had an Average Return On Invested Capital over the past 3 years of 17.26%. This is above the industry average of 12.85%.
The 3 year average ROIC (17.26%) for CLA is well above the current ROIC(%ROIC%%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -1.14%
ROE N/A
ROIC N/A
ROA(3y)-4.27%
ROA(5y)-1.67%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)17.26%
ROIC(5y)13.84%
CLA.PA Yearly ROA, ROE, ROICCLA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

The Operating Margin of CLA (8.86%) is better than 60.36% of its industry peers.
In the last couple of years the Operating Margin of CLA has grown nicely.
With a Gross Margin value of 29.19%, CLA is not doing good in the industry: 80.18% of the companies in the same industry are doing better.
CLA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.86%
PM (TTM) N/A
GM 29.19%
OM growth 3Y14.65%
OM growth 5Y11.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.23%
GM growth 5Y1.62%
CLA.PA Yearly Profit, Operating, Gross MarginsCLA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CLA is creating value.
CLA has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CLA has more shares outstanding
The debt/assets ratio for CLA has been reduced compared to a year ago.
CLA.PA Yearly Shares OutstandingCLA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CLA.PA Yearly Total Debt VS Total AssetsCLA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

CLA has an Altman-Z score of 0.63. This is a bad value and indicates that CLA is not financially healthy and even has some risk of bankruptcy.
CLA has a worse Altman-Z score (0.63) than 82.88% of its industry peers.
CLA has a debt to FCF ratio of 5.38. This is a neutral value as CLA would need 5.38 years to pay back of all of its debts.
The Debt to FCF ratio of CLA (5.38) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.38
Altman-Z 0.63
ROIC/WACCN/A
WACC7.85%
CLA.PA Yearly LT Debt VS Equity VS FCFCLA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.50 indicates that CLA may have some problems paying its short term obligations.
CLA's Current ratio of 0.50 is on the low side compared to the rest of the industry. CLA is outperformed by 90.09% of its industry peers.
A Quick Ratio of 0.45 indicates that CLA may have some problems paying its short term obligations.
With a Quick ratio value of 0.45, CLA is not doing good in the industry: 90.99% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.5
Quick Ratio 0.45
CLA.PA Yearly Current Assets VS Current LiabilitesCLA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

3

3. Growth

3.1 Past

CLA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.81%, which is quite impressive.
Looking at the last year, CLA shows a decrease in Revenue. The Revenue has decreased by -0.95% in the last year.
CLA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.58% yearly.
EPS 1Y (TTM)34.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%497.85%
Revenue 1Y (TTM)-0.95%
Revenue growth 3Y1.74%
Revenue growth 5Y13.58%
Sales Q2Q%-2.36%

3.2 Future

The Earnings Per Share is expected to grow by 28.24% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -36.73% on average over the next years. This is quite bad
EPS Next Y74.55%
EPS Next 2Y26.49%
EPS Next 3Y28.24%
EPS Next 5YN/A
Revenue Next Year-76.76%
Revenue Next 2Y-51.07%
Revenue Next 3Y-36.73%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CLA.PA Yearly Revenue VS EstimatesCLA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
CLA.PA Yearly EPS VS EstimatesCLA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2

6

4. Valuation

4.1 Price/Earnings Ratio

CLA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 8.23 indicates a reasonable valuation of CLA.
CLA's Price/Forward Earnings ratio is rather cheap when compared to the industry. CLA is cheaper than 96.40% of the companies in the same industry.
CLA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.99.
Industry RankSector Rank
PE N/A
Fwd PE 8.23
CLA.PA Price Earnings VS Forward Price EarningsCLA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

98.20% of the companies in the same industry are more expensive than CLA, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CLA is valued cheaper than 99.10% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.47
EV/EBITDA 3.05
CLA.PA Per share dataCLA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

CLA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CLA's earnings are expected to grow with 28.24% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.49%
EPS Next 3Y28.24%

0

5. Dividend

5.1 Amount

CLA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CLARANOVA SE

EPA:CLA (10/24/2025, 7:00:00 PM)

1.828

+0.08 (+4.46%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-13 2025-05-13
Earnings (Next)10-29 2025-10-29/amc
Inst Owners5.58%
Inst Owner ChangeN/A
Ins Owners5.02%
Ins Owner ChangeN/A
Market Cap104.58M
Revenue(TTM)488.60M
Net Income(TTM)-3300000
Analysts80
Price Target3.26 (78.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.25%
PT rev (3m)-7.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-7.69%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-76.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.23
P/S 0.21
P/FCF 3.47
P/OCF 2.83
P/B N/A
P/tB N/A
EV/EBITDA 3.05
EPS(TTM)-0.08
EYN/A
EPS(NY)0.22
Fwd EY12.16%
FCF(TTM)0.53
FCFY28.78%
OCF(TTM)0.64
OCFY35.28%
SpS8.54
BVpS-0.3
TBVpS-2.29
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.14%
ROE N/A
ROCE -2165%
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 8.86%
PM (TTM) N/A
GM 29.19%
FCFM 6.16%
ROA(3y)-4.27%
ROA(5y)-1.67%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)17.26%
ROIC(5y)13.84%
ROICexc(3y)46.34%
ROICexc(5y)36.95%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)23.49%
ROCE(5y)18.83%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y3.39%
ROICexc growth 5Y10.18%
OM growth 3Y14.65%
OM growth 5Y11.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.23%
GM growth 5Y1.62%
F-Score7
Asset Turnover1.69
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.38
Debt/EBITDA 0.21
Cap/Depr 55.74%
Cap/Sales 1.39%
Interest Coverage 250
Cash Conversion 66.49%
Profit Quality N/A
Current Ratio 0.5
Quick Ratio 0.45
Altman-Z 0.63
F-Score7
WACC7.85%
ROIC/WACCN/A
Cap/Depr(3y)51.75%
Cap/Depr(5y)41.72%
Cap/Sales(3y)1.22%
Cap/Sales(5y)0.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%497.85%
EPS Next Y74.55%
EPS Next 2Y26.49%
EPS Next 3Y28.24%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.95%
Revenue growth 3Y1.74%
Revenue growth 5Y13.58%
Sales Q2Q%-2.36%
Revenue Next Year-76.76%
Revenue Next 2Y-51.07%
Revenue Next 3Y-36.73%
Revenue Next 5YN/A
EBIT growth 1Y22.32%
EBIT growth 3Y16.65%
EBIT growth 5Y26.75%
EBIT Next Year-30.02%
EBIT Next 3Y-5.72%
EBIT Next 5YN/A
FCF growth 1Y323.94%
FCF growth 3Y32.3%
FCF growth 5Y48.99%
OCF growth 1Y212.71%
OCF growth 3Y28.52%
OCF growth 5Y40.7%

CLARANOVA SE / CLA.PA FAQ

Can you provide the ChartMill fundamental rating for CLARANOVA SE?

ChartMill assigns a fundamental rating of 3 / 10 to CLA.PA.


What is the valuation status of CLARANOVA SE (CLA.PA) stock?

ChartMill assigns a valuation rating of 6 / 10 to CLARANOVA SE (CLA.PA). This can be considered as Fairly Valued.


How profitable is CLARANOVA SE (CLA.PA) stock?

CLARANOVA SE (CLA.PA) has a profitability rating of 4 / 10.


How financially healthy is CLARANOVA SE?

The financial health rating of CLARANOVA SE (CLA.PA) is 2 / 10.